| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 19 |
| 1 | TACROLIMUS | 19 |
| 2 | TACROLIMUS CAPSULES | 19 |
| 3 | METHYLPREDNISOLONE | 17 |
| 4 | FLUCONAZOLE | 13 |
| 5 | MYCOPHENOLATE MOFETIL | 13 |
| 6 | VORICONAZOLE | 13 |
| 7 | MYCOPHENILIC ACID | 11 |
| 8 | MYCOPHENOLIC ACID | 11 |
| 9 | TOCILIZUMAB | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LETERMOVIR | 5 | 0.0046 |
| 1 | ANIDULAFUNGIN | 2 | 0.0022 |
| 2 | VASOPRESSIN | 4 | 0.0018 |
| 3 | MYCOPHENILIC ACID | 11 | 0.0013 |
| 4 | MICAFUNGIN SODIUM | 5 | 0.0009 |
| 5 | THIOTEPA | 5 | 0.0009 |
| 6 | GANCICLOVIR SODIUM | 6 | 0.0009 |
| 7 | REMDESIVIR | 7 | 0.0008 |
| 8 | BASILIXIMAB | 6 | 0.0008 |
| 9 | SARGRAMOSTIM | 1 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 5 | 0.0046 |
| 1 | Echinocandin Antifungal [EPC] | 7 | 0.0015 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 11 | 0.0013 |
| 3 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 7 | 0.0009 |
| 4 | Interleukin-2 Receptor Blocking Antibody [EPC] | 6 | 0.0008 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 6 | 0.0005 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 7 | Azole Antifungal [EPC] | 26 | 0.0002 |
| 8 | Oxazolidinone Antibacterial [EPC] | 4 | 0.0002 |
| 9 | Glycopeptide Antibacterial [EPC] | 8 | 0.0002 |